95 related articles for article (PubMed ID: 28760853)
1. Survival of Head and Neck Cancer Cells Relies upon LZK Kinase-Mediated Stabilization of Mutant p53.
Edwards ZC; Trotter EW; Torres-Ayuso P; Chapman P; Wood HM; Nyswaner K; Brognard J
Cancer Res; 2017 Sep; 77(18):4961-4972. PubMed ID: 28760853
[TBL] [Abstract][Full Text] [Related]
2. PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.
Ganci F; Pulito C; Valsoni S; Sacconi A; Turco C; Vahabi M; Manciocco V; Mazza EMC; Meens J; Karamboulas C; Nichols AC; Covello R; Pellini R; Spriano G; Sanguineti G; Muti P; Bicciato S; Ailles L; Strano S; Fontemaggi G; Blandino G
Clin Cancer Res; 2020 Jun; 26(12):2956-2971. PubMed ID: 31969334
[TBL] [Abstract][Full Text] [Related]
3. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
4. Functional kinomics identifies candidate therapeutic targets in head and neck cancer.
Moser R; Xu C; Kao M; Annis J; Lerma LA; Schaupp CM; Gurley KE; Jang IS; Biktasova A; Yarbrough WG; Margolin AA; Grandori C; Kemp CJ; Méndez E
Clin Cancer Res; 2014 Aug; 20(16):4274-88. PubMed ID: 25125259
[TBL] [Abstract][Full Text] [Related]
5. Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1.
Hang W; Yin ZX; Liu G; Zeng Q; Shen XF; Sun QH; Li DD; Jian YP; Zhang YH; Wang YS; Quan CS; Zhao RX; Li YL; Xu ZX
Oncogene; 2018 Jun; 37(25):3384-3398. PubMed ID: 29348462
[TBL] [Abstract][Full Text] [Related]
6. Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk
Tanaka N; Patel AA; Tang L; Silver NL; Lindemann A; Takahashi H; Jaksik R; Rao X; Kalu NN; Chen TC; Wang J; Frederick MJ; Johnson F; Gleber-Netto FO; Fu S; Kimmel M; Wang J; Hittelman WN; Pickering CR; Myers JN; Osman AA
Clin Cancer Res; 2017 Nov; 23(21):6541-6554. PubMed ID: 28790110
[No Abstract] [Full Text] [Related]
7. The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer.
Coaxum SD; Tiedeken J; Garrett-Mayer E; Myers J; Rosenzweig SA; Neskey DM
Oncotarget; 2017 Apr; 8(14):22991-23007. PubMed ID: 28160562
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers.
Cheng LH; Hung KF; Huang TF; Hsieh HP; Wang SY; Huang CY; Lo JF
Oncotarget; 2016 Nov; 7(48):78946-78957. PubMed ID: 27793047
[TBL] [Abstract][Full Text] [Related]
9. p53 modulates NF-κB mediated epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.
Lin Y; Mallen-St Clair J; Luo J; Sharma S; Dubinett S; St John M
Oral Oncol; 2015 Oct; 51(10):921-8. PubMed ID: 26306422
[TBL] [Abstract][Full Text] [Related]
10. Axon guidance molecule semaphorin3A is a novel tumor suppressor in head and neck squamous cell carcinoma.
Wang Z; Chen J; Zhang W; Zheng Y; Wang Z; Liu L; Wu H; Ye J; Zhang W; Qi B; Wu Y; Song X
Oncotarget; 2016 Feb; 7(5):6048-62. PubMed ID: 26755661
[TBL] [Abstract][Full Text] [Related]
11. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TP53 mutation-associated microRNA-182 promotes tumor cell proliferation and migration in head and neck squamous cell carcinoma.
Wang L; Jiang H; Li W; Jia C; Zhang H; Sun Y; Chen X; Song X
Arch Oral Biol; 2017 Jan; 73():105-112. PubMed ID: 27744260
[TBL] [Abstract][Full Text] [Related]
13. HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models.
Wang D; Qian G; Zhang H; Magliocca KR; Nannapaneni S; Amin AR; Rossi M; Patel M; El-Deiry M; Wadsworth JT; Chen Z; Khuri FR; Shin DM; Saba NF; Chen ZG
Clin Cancer Res; 2017 Feb; 23(3):677-686. PubMed ID: 27358485
[TBL] [Abstract][Full Text] [Related]
14. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.
Li D; Day KV; Yu S; Shi G; Liu S; Guo M; Xu Y; Sreedharan S; O'Malley BW
Cancer Res; 2002 Aug; 62(16):4637-44. PubMed ID: 12183420
[TBL] [Abstract][Full Text] [Related]
15. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
[TBL] [Abstract][Full Text] [Related]
16. MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin.
Wen Y; Li H; Zeng Y; Wen W; Pendleton KP; Lui VW; Egloff AM; Grandis JR
Oncotarget; 2016 Apr; 7(17):23300-11. PubMed ID: 27004400
[TBL] [Abstract][Full Text] [Related]
17. Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma.
Di Agostino S; Valenti F; Sacconi A; Fontemaggi G; Pallocca M; Pulito C; Ganci F; Muti P; Strano S; Blandino G
Theranostics; 2018; 8(7):1850-1868. PubMed ID: 29556360
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo.
Gu X; Song X; Dong Y; Cai H; Walters E; Zhang R; Pang X; Xie T; Guo Y; Sridhar R; Califano JA
Clin Cancer Res; 2008 Mar; 14(6):1840-8. PubMed ID: 18347187
[TBL] [Abstract][Full Text] [Related]
19. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
Liu CJ; Shen WG; Peng SY; Cheng HW; Kao SY; Lin SC; Chang KW
Int J Cancer; 2014 Feb; 134(4):811-21. PubMed ID: 23824713
[TBL] [Abstract][Full Text] [Related]
20. Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma.
Li F; Shanmugam MK; Chen L; Chatterjee S; Basha J; Kumar AP; Kundu TK; Sethi G
Cancer Prev Res (Phila); 2013 Aug; 6(8):843-54. PubMed ID: 23803415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
